Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

Sponsor
University Hospital, Caen (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05563883
Collaborator
University Hospital, Tours (Other)
5,000,000
1
87.3
57256.4

Study Details

Study Description

Brief Summary

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known.

The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

Condition or Disease Intervention/Treatment Phase
  • Other: event occurence

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Actual Study Start Date :
Sep 22, 2022
Anticipated Primary Completion Date :
Jan 1, 2030
Anticipated Study Completion Date :
Jan 1, 2030

Outcome Measures

Primary Outcome Measures

  1. atrial fibrillation [from inclusion in the cohort up to 10 years]

    occurrence of atrial fibrillation

  2. cancer [ffrom inclusion in the cohort up to 10 years]

    occurrence of cancer

Secondary Outcome Measures

  1. thromboembolism [from inclusion in the cohort up to 10 years]

    occurrence of thromboembolism

  2. bleeding [from inclusion in the cohort up to 10 years]

    occurrence of bleeding

  3. mortality [from inclusion in the cohort up to 10 years]

    occurrence of mortality

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • adult hospitalized patients

  • with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information)

Exclusion Criteria:
  • children

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Cardiologie, Centre Hospitalier Universitaire Trousseau Tours France 37000

Sponsors and Collaborators

  • University Hospital, Caen
  • University Hospital, Tours

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joachim ALEXANDRE, Prof, University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT05563883
Other Study ID Numbers:
  • PMSI_092022
First Posted:
Oct 3, 2022
Last Update Posted:
Oct 3, 2022
Last Verified:
Sep 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2022